Concepedia

Alexandros Vakalopoulos

AV

Statistics

Publications

14

Citations

474

H-Index

12

Active since

2000

Affiliations

Bayer (Germany)(Current)

Leibniz University Hannover

Bayer (United States)

TU Dortmund University

Alexandros Vakalopoulos is an author at Bayer (Germany) specializing in pharmacology, medicinal chemistry, and chemistry.

ORCID

Top concepts

Publications per year

2000–2023

14

Publications

14

Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity

Joachim Rudolph, William P. Esler, Stephen O’Connor et al. · Journal of Medicinal Chemistry · 2007 · 157 citations · Full text

, , +17

Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A<sub>1</sub> Receptor Agonist for the Chronic Treatment of Heart Diseases

Daniel Meibom, Barbara Albrecht‐Küpper, Nicole Diedrichs et al. · ChemMedChem · 2017 · 54 citations

Novel Deprotection of SEM Ethers:  A Very Mild and Selective Method Using Magnesium Bromide

Alexandros Vakalopoulos, H. M. R. Hoffmann · Organic Letters · 2000 · 43 citations

Versatile 8-Oxabicyclo[3.2.1]oct-6-en-3-one:  Stereoselective Methodology for Generating<i>C</i>-Glycosides, δ-Valerolactones, and Polyacetate Segments

Alexandros Vakalopoulos, H. M. R. Hoffmann · Organic Letters · 2000 · 31 citations

Asymmetric Synthesis of the Northern Half C1−C16 of the Bryostatins

Alexandros Vakalopoulos, Thomas Lampe, H. M. R. Hoffmann · Organic Letters · 2001 · 31 citations

1–5 of 14